All companies
AIM:IOF · Basic Materials · Specialty chemicals — iodine exploration/production from oilfield brine and manufacture of iodine-based specialty chemical derivatives
Iofina plc logo

Iofina plc

Iofina plc is an AIM-listed holding company whose wholly owned subsidiaries extract iodine from brine water co-produced by third-party oil and gas operations in Oklahoma (and, from 2026, the Permian Basin) using its proprietary WET/IOsorb technology, and manufacture and sell iodine and halogen-based specialty chemical derivatives through Iofina Chemical. The Group is vertically integrated from brine-sourced crystalline iodine production through to derivative chemicals sold to a global customer base, and believes it is the second-largest iodine producer in North America.

The latest annual report

FY2025 in sixty seconds

year to 31 Dec 2025 · approved 29 Apr 2026 · 91 pages · Companies House

Open the reportJSONComing soon

Iofina plc extracts iodine from the salty water that comes up with oil and gas in Oklahoma, and makes specialty chemicals from it. In the year to 31 December 2025, revenue rose to $66.5m from $54.5m, and profit after tax rose to $7.9m from $2.9m.

The report gives two main reasons: the company produced more iodine, helped by a new plant that opened in July 2025, and it sold iodine at a higher average price of $74.02/kg. Profit was also lifted by a one-off gain from US government payroll subsidies linked to COVID-19.

Cash at the year end was $11.7m, up from $6.9m, while borrowings rose to $6.5m from $3.9m. The directors do not recommend a dividend, as they plan to fund growth from the company's own cash and bank loans. Management expects a new plant in the Permian Basin to start up in the third quarter of 2026, taking annual production to around 1,000 metric tonnes, and expects iodine prices to stay firm. The auditor raised no concerns. The risks listed include a fall in iodine prices, reliance on other companies for the salty water, and dependence on a small number of customers.

From the reportevery line sits on the page it names
What drove revenue

Crystallised iodine production volume growth (743MT in 2025 vs 634MT in 2024, +17%)

Iodine production increased by 109MT (17%) to 743MT; new IOsorb plant IO#11 commissioned July 2025

page 10
What moved the margintailwind

Operational gearing from IOsorb plant network as production volumes scale

Gross profit margin rose from 24% to 27% of sales; average production cost per kg only 2% higher than 2024 despite 17% production growth

page 10
What management said

Before the end of 2026, Iofina will reach an annualised production rate, with the addition of our newest plant coming online in the third quarter, in the region of 1,000 metric tonnes, taking it close to becoming the largest iodine producer in North America.

page 3
The dividend

The directors do not recommend payment of a dividend for 2025.

page 30

All 10 years' reports, read the same way

Key figures

11 years on one page · FY2015–FY2025

The share price over the full statements

LineFY2015lockedFY2016lockedFY2017lockedFY2018lockedFY2019lockedFY2020lockedFY2021lockedFY2022lockedFY202312/23FY202412/24FY202512/25
Revenue
Operating profit
Profit for the year
Basic EPS
Free cash flow
Net debt (negative = net cash)
Shares in issue
Operating margin
Return on capital employed

USD millions, negatives in brackets. Per-share lines in cents. Share counts in millions. Margins and returns as percentages, calculated from the filed figures. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated.

Read twice

Nothing restated

Every figure is read again from the following year’s report: 337 confirmed, 8 differ.

No figure has been restated: every figure a later report printed again, it printed the same.